Results 191 to 200 of about 22,921 (213)

Cardiovascular Outcomes of Calcium-Free vs Calcium-Based Phosphate Binders in Patients 65 Years or Older With End-stage Renal Disease Requiring Hemodialysis.

JAMA Intern Med, 2019
Spoendlin J, Paik JM, Tsacogianis T, Kim SC, Schneeweiss S, Desai RJ.   +5 more
europepmc   +1 more source

Treatment Satisfaction with Tenapanor: Real-World Survey of Patients with End-Stage Renal Disease and Hyperphosphatemia. [PDF]

Patient Prefer Adherence
Kendrick JB, Scott LL, Gist B, Williams LA.   +3 more
europepmc   +1 more source

Multifunctional Crosslinked PAA-TA Binder: Robust Structural Integrity and Suppressed Manganese Dissolution for High-Performance LiMn_0.6Fe_0.4PO₄ Cathodes. [PDF]

Polymers (Basel)
Zhou J, Zhao W, Xu J, Li Y, Zheng F, Chen A, Tong J, Liu Y, Zhong H.   +8 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

An update on phosphate binders for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis: a review of safety profiles

Expert Opinion on Drug Safety, 2022
Hiroaki Ogata
exaly  

Effect of Tenapanor on Phosphate Binder Pill Burden in Hemodialysis Patients

Kidney International Reports, 2021
Kazuaki Ikejiri, Tadao Akizawa, Masafumi Fukagawa   +2 more
exaly  

Phosphate binders in chronic kidney disease: a systematic review of recent data

Journal of Nephrology, 2016
Jürgen Floege
exaly  

Next-Generation Phosphate Binders: Focus on Iron-Based Binders

Drugs, 2014
Maria Dolores Sanchez-niño, Beatriz Fernández-Fernández, Alberto Ortiz   +2 more
exaly  

Benefits and Harms of Phosphate Binders in CKD: A Systematic Review of Randomized Controlled Trials

American Journal of Kidney Diseases, 2009
Grahame Elder, Jonathan Craig, Giovanni Strippoli   +2 more
exaly  

Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients

Kidney International, 2007
Antonio Bellasi, Paolo Raggi, G A Block
exaly